Dodge & Cox Has $2.59 Billion Stock Position in Humana Inc. (NYSE:HUM)

Dodge & Cox raised its holdings in shares of Humana Inc. (NYSE:HUM - Free Report) by 106.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,198,040 shares of the insurance provider's stock after acquiring an additional 5,264,045 shares during the quarter. Humana makes up approximately 1.5% of Dodge & Cox's holdings, making the stock its 22nd biggest position. Dodge & Cox owned approximately 8.47% of Humana worth $2,587,345,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. FPC Investment Advisory Inc. acquired a new stake in Humana in the 4th quarter valued at $27,000. Centricity Wealth Management LLC bought a new position in shares of Humana in the 4th quarter valued at about $30,000. LFA Lugano Financial Advisors SA raised its holdings in Humana by 56.3% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after acquiring an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new position in Humana during the fourth quarter valued at approximately $33,000. Finally, Atwood & Palmer Inc. boosted its position in Humana by 64.5% during the fourth quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock valued at $39,000 after purchasing an additional 60 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on HUM shares. Royal Bank of Canada reissued an "outperform" rating and issued a $283.00 price objective on shares of Humana in a report on Wednesday, February 12th. Robert W. Baird increased their price target on shares of Humana from $270.00 to $300.00 and gave the company a "neutral" rating in a research note on Tuesday, April 15th. Guggenheim assumed coverage on shares of Humana in a research note on Wednesday, April 9th. They set a "buy" rating and a $326.00 price objective on the stock. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 target price on shares of Humana in a report on Wednesday, February 12th. Finally, JPMorgan Chase & Co. reduced their price target on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a report on Tuesday, February 18th. Seventeen equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $284.90.

Humana Price Performance

NYSE:HUM traded down $21.20 during trading hours on Friday, reaching $264.41. 3,670,273 shares of the company were exchanged, compared to its average volume of 1,759,722. The company has a market capitalization of $31.91 billion, a P/E ratio of 26.57, a P/E/G ratio of 2.05 and a beta of 0.62. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.76 and a quick ratio of 1.76. The business has a 50 day moving average of $265.90 and a 200 day moving average of $270.03.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.34%. Humana's dividend payout ratio is currently 35.58%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.